Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Halpert, JR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 80 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eiselt, R; Domanski, TL; Zibat, A; Mueller, R; Presecan-Siedel, E; Hustert, E; Zanger, UM; Brockmoller, J; Klenk, HP; Meyer, UA; Khan, KK; He, YA; Halpert, JR; Wojnowski, L
      Identification and functional characterization of eight CYP3A4 protein variants

      PHARMACOGENETICS
    2. Xue, LL; Wang, HF; Wang, QM; Szklarz, GD; Domanski, TL; Halpert, JR; Correia, MA
      Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B-1 oxidation

      CHEMICAL RESEARCH IN TOXICOLOGY
    3. Fontaine, SM; Hoyer, PB; Halpert, JR; Sipes, IG
      Role of induction of specific hepatic cytochrome P450 isoforms in epoxidation of 4-vinylcyclohexene

      DRUG METABOLISM AND DISPOSITION
    4. Ferrari, L; Peng, N; Halpert, JR; Morgan, ET
      Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, inprimary cultures of rat hepatocytes

      MOLECULAR PHARMACOLOGY
    5. Spatzenegger, M; Wang, QM; He, YQ; Wester, MR; Johnson, EF; Halpert, JR
      Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles

      MOLECULAR PHARMACOLOGY
    6. Domanski, TL; Finta, C; Halpert, JR; Zaphiropoulos, PG
      cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome p450

      MOLECULAR PHARMACOLOGY
    7. Domanski, TL; He, YA; Khan, KK; Roussel, F; Wang, QM; Halpert, JR
      Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity

      BIOCHEMISTRY
    8. Scott, EE; Spatzenegger, M; Halpert, JR
      A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    9. Domanski, TL; He, YQ; Scott, EE; Wang, QM; Halpert, JR
      The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    10. He, YQ; Roussel, F; Halpert, JR
      Importance of amino acid residue 474 for substrate specificity of canine and human cytochrome p450 3A enzymes

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    11. Domanski, TL; He, YA; Harlow, GR; Halpert, JR
      Dual role of human cytochrome P450 3A4 residue phe-304 in substrate specificity and cooperativity

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    12. Roussel, F; Khan, KK; Halpert, JR
      The importance of SRS-1 residues in catalytic specificity of human cytochrome p450 3A4

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    13. Khan, KK; Halpert, JR
      Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    14. Ourlin, JC; Baader, M; Fraser, D; Halpert, JR; Meyer, UA
      Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37)

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    15. Waller, SC; He, YA; Harlow, GR; He, YQ; Mash, EA; Halpert, JR
      2,2 ',3,3 ',6,6 '-hexachlorobiphenyl hydroxylation by active site mutants of cytochrome P4502B1 and 2B11

      CHEMICAL RESEARCH IN TOXICOLOGY
    16. Doerr-Stevens, JK; Liu, JP; Stevens, GJ; Kraner, JC; Fontaine, SM; Halpert, JR; Sipes, IG
      Induction of cytochrome P-450 enzymes after repeated exposure to 4-vinylcyclohexene in B6C3F(1) mice

      DRUG METABOLISM AND DISPOSITION
    17. Fraser, DJ; He, YQ; Harlow, GR; Halpert, JR
      Use of chimeric enzymes and site-directed mutagenesis for identification of three key residues responsible for differences in steroid hydroxylation between canine cytochromes P-450 3A12 and 3A26

      MOLECULAR PHARMACOLOGY
    18. Domanski, TL; Schultz, KM; Roussel, F; Stevens, JC; Halpert, JR
      Structure-function analysis of human cytochrome P-4502B6 using a novel substrate, site-directed mutagenesis, and molecular modeling

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Stevens, JC; Domanski, TL; Harlow, GR; White, RB; Orton, E; Halpert, JR
      Use of the steroid derivative RPR 106541 in combination with site-directedmutagenesis for enhanced cytochrome P-450 3A4 structure/function analysis

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    20. Strobel, SM; Szklarz, GD; He, YQ; Foroozesh, M; Alworth, WL; Roberts, ES; Hollenberg, PF; Halpert, JR
      Identification of selective mechanism-based inactivators of cytochromes P-4502B4 and 2B5, and determination of the molecular basis for differential susceptibility

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    21. KOBAYASHI Y; STROBEL SM; HOPKINS NE; ALWORTH WL; HALPERT JR
      CATALYTIC PROPERTIES OF AN EXPRESSED CYTOCHROME-P450 2B1 FROM A WISTAR-KYOTO RAT-LIVER CDNA LIBRARY

      Drug metabolism and disposition
    22. Halpert, JR
      Anthony Y. H. Lu commemorative issue - Preface

      DRUG METABOLISM AND DISPOSITION
    23. Szklarz, GD; Halpert, JR
      Molecular basis of P450 inhibition and activation - Implications for drug development and drug therapy

      DRUG METABOLISM AND DISPOSITION
    24. Halpert, JR; Domanski, TL; Adali, O; Biagini, CP; Cosme, J; Dierks, EA; Johnson, EF; Jones, JP; de Montellano, PO; Philpot, RM; Sibbesen, O; Wyatt, WK; Zheng, ZP
      Structure-function of cytochromes P450 and flavin-containing monooxygenases - Implications for drug metabolism

      DRUG METABOLISM AND DISPOSITION
    25. HARLOW GR; HALPERT JR
      ANALYSIS OF HUMAN CYTOCHROME-P450 3A4 COOPERATIVITY - CONSTRUCTION AND CHARACTERIZATION OF A SITE-DIRECTED MUTANT THAT DISPLAYS HYPERBOLIC STEROID HYDROXYLATION KINETICS

      Proceedings of the National Academy of Sciences of the United Statesof America
    26. WANG HF; DICK R; YIN HQ; LICADCOLES E; KROETZ DL; SZKLARZ G; HARLOW G; HALPERT JR; CORREIA MA
      STRUCTURE-FUNCTION-RELATIONSHIPS OF HUMAN LIVER CYTOCHROMES P450 3A -AFLATOXIN-B1 METABOLISM AS A PROBE

      Biochemistry
    27. KOBAYASHI Y; FANG XJ; SZKLARZ GD; HALPERT JR
      PROBING THE ACTIVE-SITE OF CYTOCHROME-P450 2B1 - METABOLISM OF 7-ALKOXYCOUMARINS BY THE WILD-TYPE AND 5 SITE-DIRECTED MUTANTS

      Biochemistry
    28. DOMANSKI TL; LIU JP; HARLOW GR; HALPERT JR
      ANALYSIS OF 4 RESIDUES WITHIN SUBSTRATE RECOGNITION SITE-4 OF HUMAN CYTOCHROME-P450 3A4 - ROLE IN STEROID HYDROXYLASE-ACTIVITY AND ALPHA-NAPHTHOFLAVONE STIMULATION

      Archives of biochemistry and biophysics
    29. HE YQ; HARLOW GR; SZKLARZ GD; HALPERT JR
      STRUCTURAL DETERMINANTS OF PROGESTERONE HYDROXYLATION BY CYTOCHROME-P450 2B5 - THE ROLE OF NONSUBSTRATE RECOGNITION SITE RESIDUES

      Archives of biochemistry and biophysics
    30. SZKLARZ GD; HALPERT JR
      MOLECULAR MODELING OF CYTOCHROME-P450 3A4

      Journal of computer-aided molecular design
    31. HALPERT JR; DOMANSKI T; FANG X; HARLOW GR; HE YA; HE YO; KOBAYASHI Y; STROBEL SM; SZKLARZ GD
      MOLECULAR-BASIS OF P450 2B AND 3A SPECIFICITY - MUTANTS, MODELS, AND MECHANISMS

      The FASEB journal
    32. HE YA; HE YQ; SZKLARZ GD; HALPERT JR
      IDENTIFICATION OF KEY RESIDUES IN HUMAN CYTOCHROME-P450 3A4 BY CASSETTE, SITE-DIRECTED AND RANDOM MUTAGENESIS

      The FASEB journal
    33. DOMANSKI TL; HARLOW GR; HALPERT JR
      MUTAGENESIS OF RESIDUES WITHIN SRS-2 AND SRS-4 OF HUMAN CYTOCHROME-P450 3A4 AND THE EFFECT ON HYDROXYLASE-ACTIVITY AND STIMULATION BY ALPHA-NAPHTHOFLAVONE

      The FASEB journal
    34. STROBEL SM; HALPERT JR
      HETEROLOGOUS EXPRESSION OF A P450 2B2 CDNA CLONE - ACTIVITY AND SUBSTRATE-SPECIFICITY

      The FASEB journal
    35. FANG X; KOBAYASHI Y; HALPERT JR
      STOICHIOMETRY OF 7-ETHOXYCOUMARIN METABOLISM BY WILD-TYPE P450 2B1 AND 5 ACTIVE-SITE MUTANTS

      The FASEB journal
    36. HE YQ; HALPERT JR
      MOLECULAR-BASIS OF THE PROGESTERONE HYDROXYLASE SPECIFICITY OF CYTOCHROME-P450 2B5

      The FASEB journal
    37. KENT UM; HANNA IH; SZKLARZ GD; VAZ ADN; HALPERT JR; BEND JR; HOLLENBERG PF
      SIGNIFICANCE OF GLYCINE-478 IN CYTOCHROME-P450 2B1 ON THE METABOLISM OF N-BENZYL-1-AMINOBENZOTRIAZOLE

      The FASEB journal
    38. FRASER DJ; FEYEREISEN R; HARLOW GR; HALPERT JR
      ISOLATION, HETEROLOGOUS EXPRESSION, AND FUNCTIONAL-CHARACTERIZATION OF A NOVEL CYTOCHROME-P450 3A ENZYME FROM A CANINE CDNA LIBRARY

      The FASEB journal
    39. HARLOW GR; HE YA; HALPERT JR
      FUNCTIONAL INTERACTION BETWEEN AMINO-ACID-RESIDUE-242 AND AMINO-ACID-RESIDUE-290 IN CYTOCHROMES P-450 2B1 AND 2B11

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    40. ROBERTS ES; HOPKINS NE; FOROOZESH M; ALWORTH WL; HALPERT JR; HOLLENBERG PF
      INACTIVATION OF CYTOCHROME P450S 2B1, 2B4, 2B6, AND 2B11 BY ARYLALKYNES

      Drug metabolism and disposition
    41. SZKLARZ GD; HALPERT JR
      USE OF HOMOLOGY MODELING IN CONJUNCTION WITH SITE-DIRECTED MUTAGENESIS FOR ANALYSIS OF STRUCTURE-FUNCTION-RELATIONSHIPS OF MAMMALIAN CYTOCHROMES P450

      Life sciences
    42. FRASER DJ; FEYEREISEN R; HARLOW GR; HALPERT JR
      ISOLATION, HETEROLOGOUS EXPRESSION AND FUNCTIONAL-CHARACTERIZATION OFA NOVEL CYTOCHROME-P450 3A ENZYME FROM A CANINE LIVER CDNA LIBRARY

      The Journal of pharmacology and experimental therapeutics
    43. HARLOW GR; HALPERT JR
      ALANINE-SCANNING MUTAGENESIS OF A PUTATIVE SUBSTRATE RECOGNITION SITEIN HUMAN CYTOCHROME-P450 3A4 - ROLE OF RESIDUE-210 AND RESIDUE-211 INFLAVONOID ACTIVATION AND SUBSTRATE-SPECIFICITY

      The Journal of biological chemistry
    44. FANG XJ; KOBAYASHI Y; HALPERT JR
      STOICHIOMETRY OF 7-ETHOXYCOUMARIN METABOLISM BY CYTOCHROME-P450 2B1 WILD-TYPE AND 5 ACTIVE-SITE MUTANTS

      FEBS letters
    45. STROBEL SM; HALPERT JR
      REASSESSMENT OF CYTOCHROME-P450 2B2 - CATALYTIC SPECIFICITY AND IDENTIFICATION OF 4 ACTIVE-SITE RESIDUES

      Biochemistry
    46. KENT UM; HANNA IH; SZKLARZ GD; VAZ ADN; HALPERT JR; BEND JR; HOLLENBERG PF
      SIGNIFICANCE OF GLYCINE-478 IN THE METABOLISM OF N-BENZYL-1-AMINOBENZOTRIAZOLE TO REACTIVE INTERMEDIATES BY CYTOCHROME-P450 2B1

      Biochemistry
    47. HE YA; HE YQ; SZKLARZ GD; HALPERT JR
      IDENTIFICATION OF 3 KEY RESIDUES IN SUBSTRATE RECOGNITION SITE-5 OF HUMAN CYTOCHROME-P450 3A4 BY CASSETTE AND SITE-DIRECTED MUTAGENESIS

      Biochemistry
    48. FANG XJ; HALPERT JR
      DITHIONITE-SUPPORTED HYDROXYLATION OF PALMITIC ACID BY CYTOCHROME P450BM-3

      Drug metabolism and disposition
    49. POET TS; MCQUEEN CA; HALPERT JR
      PARTICIPATION OF CYTOCHROMES P4502B AND P4503A IN COCAINE TOXICITY INRAT HEPATOCYTES

      Drug metabolism and disposition
    50. BORN SL; FRASER DJ; HARLOW GR; HALPERT JR
      ESCHERICHIA-COLI EXPRESSION AND SUBSTRATE SPECIFICITIES OF CANINE CYTOCHROME-P450 3A12 AND RABBIT CYTOCHROME-P450 3A6

      The Journal of pharmacology and experimental therapeutics
    51. KRANER JC; MORGAN ET; POET TS; BORN SL; BURNETT VL; HALPERT JR
      SUPPRESSION OF RAT HEPATIC-MICROSOMAL CYTOCHROMES P450 BY CYCLOPHOSPHAMIDE IS CORRELATED WITH PLASMA THYROID-HORMONE LEVELS AND DISPLAYS DIFFERENTIAL STRAIN SENSITIVITY

      The Journal of pharmacology and experimental therapeutics
    52. HE K; HE YA; SZKLARZ GD; HALPERT JR; CORREIA MA
      SECOBARBITAL-MEDIATED INACTIVATION OF CYTOCHROME-P450 2B1 AND ITS ACTIVE-SITE MUTANTS - PARTITIONING BETWEEN HEME AND PROTEIN ALKYLATION AND EPOXIDATION

      The Journal of biological chemistry
    53. HE YQ; SZKLARZ GD; HALPERT JR
      INTERCONVERSION OF THE ANDROSTENEDIONE HYDROXYLASE SPECIFICITIES OF CYTOCHROMES P450 2B4 AND 2B5 UPON SIMULTANEOUS SITE-DIRECTED MUTAGENESIS OF 4 KEY SUBSTRATE RECOGNITION RESIDUES

      Archives of biochemistry and biophysics
    54. SZKLARZ GD; HE YQ; KEDZIE KM; HALPERT JR; BURNETT VL
      ELUCIDATION OF AMINO-ACID-RESIDUES CRITICAL FOR UNIQUE ACTIVITIES OF RABBIT CYTOCHROME-P450 2B5 USING HYBRID ENZYMES AND RECIPROCAL SITE-DIRECTED MUTAGENESIS WITH RABBIT CYTOCHROME-P450 2B4

      Archives of biochemistry and biophysics
    55. LIU JP; HE YA; HALPERT JR
      ROLE OF RESIDUE-480 IN SUBSTRATE-SPECIFICITY OF CYTOCHROME-P450 2B5 AND 2B11

      Archives of biochemistry and biophysics
    56. HARLOW GR; HALPERT JR
      MUTAGENESIS STUDY OF ASP-290 IN CYTOCHROME-P450 2B11 USING A FUSION PROTEIN WITH RAT NADPH-CYTOCHROME P450 REDUCTASE

      Archives of biochemistry and biophysics
    57. HE YQ; HE YA; HALPERT JR
      ESCHERICHIA-COLI EXPRESSION OF SITE-DIRECTED MUTANTS OF CYTOCHROME-P450 2B1 FROM 6 SUBSTRATE RECOGNITION SITES - SUBSTRATE-SPECIFICITY AND INHIBITOR SELECTIVITY STUDIES

      Chemical research in toxicology
    58. HALPERT JR
      STRUCTURAL BASIS OF SELECTIVE CYTOCHROME-P450 INHIBITION

      Annual review of pharmacology and toxicology
    59. BORN SL; JOHN GH; HARLOW GR; HALPERT JR
      CHARACTERIZATION OF THE PROGESTERONE 21-HYDROXYLASE ACTIVITY OF CANINE CYTOCHROME-P450 PBD-2 P450 2B11 THROUGH RECONSTITUTION, HETEROLOGOUSEXPRESSION, AND SITE-DIRECTED MUTAGENESIS/

      Drug metabolism and disposition
    60. GRIMM SW; BEND JR; HALPERT JR
      SELECTIVITY AND KINETICS OF INACTIVATION OF RABBIT HEPATIC CYTOCHROMES P450 2B4 AND 2B5 BY N-ARALKYLATED DERIVATIVES OF 1-AMINOBENZOTRIAZOLE

      Drug metabolism and disposition
    61. KLEKOTKA PA; HALPERT JR
      BENZYLOXYRESORUFIN AS A SPECIFIC SUBSTRATE FOR THE MAJOR PHENOBARBITAL-INDUCIBLE DOG LIVER CYTOCHROME-P450 (P4502B11)

      Drug metabolism and disposition
    62. KLEKOTKA PA; RICHARDSON TH; JOHNSON EF; HALPERT JR
      INACTIVATION OF ESCHERICHIA-COLI EXPRESSED RABBIT CYTOCHROME-P-450 2CENZYMES BY 17-BETA-SUBSTITUTED STEROIDS

      The Journal of pharmacology and experimental therapeutics
    63. SZKLARZ GD; HE YA; HALPERT JR
      SITE-DIRECTED MUTAGENESIS AS A TOOL FOR MOLECULAR MODELING OF CYTOCHROME-P450 2B1

      Biochemistry
    64. BORN SL; JOHN GH; HALPERT JR
      CHARACTERIZATION OF THE PROGESTERONE 21-HYDROXYLASE ACTIVITY OF CANINE CYTOCHROME-P450-2B11

      The FASEB journal
    65. SZKLARZ GD; ORNSTEIN RL; HALPERT JR
      MOLECULAR MODELING OF CYTOCHROME-P450-2B1 AS A TOOL FOR UNDERSTANDINGSTRUCTURE-FUNCTION-RELATIONSHIPS

      The FASEB journal
    66. GRIMM SW; PHILPOT RM; BEND JR; HALPERT JR
      DIFFERENTIAL SUBSTRATE-SPECIFICITY AND MECHANISM-BASED INACTIVATION OF RABBIT CYTOCHROME-P450-2B4 AND CYTOCHROME-P450-2B5

      The FASEB journal
    67. SZKLARZ GD; ORNSTEIN RL; HALPERT JR
      APPLICATION OF 3-DIMENSIONAL HOMOLOGY MODELING OF CYTOCHROME-P450 2B1FOR INTERPRETATION OF SITE-DIRECTED MUTAGENESIS RESULTS

      Journal of biomolecular structure & dynamics
    68. LAETHEM RM; HALPERT JR; KOOP DR
      EPOXIDATION OF ARACHIDONIC-ACID AS AN ACTIVE-SITE PROBE OF CYTOCHROME-P-450 2B ISOFORMS

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    69. POET TS; BRENDEL K; HALPERT JR
      INACTIVATION OF CYTOCHROMES P450 2B PROTECTS AGAINST COCAINE-MEDIATEDTOXICITY IN RAT-LIVER SLICES

      Toxicology and applied pharmacology
    70. HALPERT JR; GUENGERICH FP; BEND JR; CORREIA MA
      SELECTIVE INHIBITORS OF CYTOCHROMES P450

      Toxicology and applied pharmacology
    71. GRIMM SW; DYROFF MC; PHILPOT RM; HALPERT JR
      CATALYTIC SELECTIVITY AND MECHANISM-BASED INACTIVATION OF STABLY EXPRESSED AND HEPATIC CYTOCHROMES P450 2B4 AND 2B5 - IMPLICATIONS OF THE CYTOCHROME-P450 2B5 POLYMORPHISM

      Molecular pharmacology
    72. HASLER JA; HARLOW GR; SZKLARZ GD; JOHN GH; KEDZIE KM; BURNETT VL; HE YA; KAMINSKY LS; HALPERT JR
      SITE-DIRECTED MUTAGENESIS OF PUTATIVE SUBSTRATE RECOGNITION SITES IN CYTOCHROME-P450-2B11 - IMPORTANCE OF AMINO-ACID RESIDUE-114, RESIDUE-290, AND RESIDUE-363 FOR SUBSTRATE-SPECIFICITY

      Molecular pharmacology
    73. KRANER JC; MORGAN ET; HALPERT JR
      SELECTIVE SUPPRESSION OF RAT HEPATIC CYTOCHROME-P450 2C11 BY CHLORAMPHENICOL

      The Journal of pharmacology and experimental therapeutics
    74. ELIASSON E; MKRTCHIAN S; HALPERT JR; INGELMANSUNDBERG M
      SUBSTRATE-REGULATED, CAMP-DEPENDENT PHOSPHORYLATION, DENATURATION, AND DEGRADATION OF GLUCOCORTICOID-INDUCIBLE RAT-LIVER CYTOCHROME-P450 3A1

      The Journal of biological chemistry
    75. HE YA; LUO ZS; KLEKOTKA PA; BURNETT VL; HALPERT JR
      STRUCTURAL DETERMINANTS OF CYTOCHROME-P450-2B1 SPECIFICITY - EVIDENCEFOR 5 SUBSTRATE RECOGNITION SITES

      Biochemistry
    76. JOHN GH; HASLER JA; HE YA; HALPERT JR
      ESCHERICHIA-COLI EXPRESSION AND CHARACTERIZATION OF CYTOCHROMES P450 2B11, 2B1, AND 2B5

      Archives of biochemistry and biophysics
    77. JOHN GH; HASLER JA; HE YA; HALPERT JR
      ESCHERICHIA-COLI EXPRESSION AND CHARACTERIZATION OF CYTOCHROMES P450 2B11, 2B1, AND 2B5

      Archives of biochemistry and biophysics
    78. LOU ZS; HE YA; HALPERT JR
      ROLE OF RESIDUE-363 AND RESIDUE-206 IN CONVERSION OF CYTOCHROME-P450 2B1 FROM A STEROID 16-HYDROXYLASE TO A 15-ALPHA-HYDROXYLASE

      Archives of biochemistry and biophysics
    79. KEDZIE KM; GRIMM SW; CHEN F; HALPERT JR
      HYBRID ENZYMES FOR STRUCTURE-FUNCTION ANALYSIS OF CYTOCHROME-P-450-2B11

      Biochimica et biophysica acta
    80. RYAN R; GRIMM SW; KEDZIE KM; HALPERT JR; PHILPOT RM
      CLONING, SEQUENCING, AND FUNCTIONAL-STUDIES OF PHENOBARBITAL-INDUCIBLE FORMS OF CYTOCHROME-P450-2B AND CYTOCHROME-P450-4B EXPRESSED IN RABBIT KIDNEY

      Archives of biochemistry and biophysics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 22:08:00